Cetrotide 0.25 mg

Cetrotide is a medicine that is used to treat ovarian cancer and other cancers. It belongs to the group of gonadotropins and antigonadotropins, that is, substances that regulate the functioning of the sex glands.

Cetrotide is manufactured by Baxter Oncology GmbH (Germany). It is available in the form of a lyophilized powder for the preparation of an injection solution. The dosage of the drug is 0.25 mg.

The drug Cetrotide has several synonyms, such as Cetrorelix and Cetrotide-3. They differ from each other only in dosage and manufacturer.

The use of Cetrotide can only be prescribed by a doctor after a thorough examination of the patient and assessment of his condition. The drug is administered intravenously or subcutaneously.

The effectiveness of Cetrotide depends on the individual characteristics of the patient, the stage of the disease and other factors. However, overall, this drug may help reduce tumor size and improve a patient's quality of life.